{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T17:09:21Z","timestamp":1789751361800,"version":"4.0.1"},"reference-count":75,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Ultrasound, CT and MRI"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1053\/j.sult.2026.06.014","type":"journal-article","created":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T15:00:35Z","timestamp":1783090835000},"page":"360-373","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Neuroendocrine Carcinoma of Cervix: Comprehensive Review of Epidemiology, Pathology, and Advanced Imaging Modalities"],"prefix":"10.1053","volume":"47","author":[{"given":"Dorsa","family":"Dayani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nisha","family":"Ramani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel Assumpcao Chahine","family":"Hage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayur","family":"Virarkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priya","family":"Bhosale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1053\/j.sult.2026.06.014_bib1","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1186\/s12885-018-4447-x","article-title":"Neuroendocrine carcinoma of the cervix: A systematic review of the literature","volume":"18","author":"Tempfer","year":"2018","journal-title":"BMC Cancer"},{"issue":"2","key":"10.1053\/j.sult.2026.06.014_bib2","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.ygyno.2016.02.008","article-title":"Natural history and outcome of neuroendocrine carcinoma of the cervix","volume":"141","author":"Margolis","year":"2016","journal-title":"Gynecol Oncol"},{"key":"10.1053\/j.sult.2026.06.014_bib3","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.ygyno.2023.01.036","article-title":"The role of postoperative radiation after radical hysterectomy for women with early-stage neuroendocrine carcinoma of the cervix: A meta-analysis","volume":"170","author":"Kim","year":"2023","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1053\/j.sult.2026.06.014_bib4","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0090-8258(02)00150-6","article-title":"Endocrine tumors of the uterine cervix: Incidence, demographics, and survival with comparison to squamous cell carcinoma","volume":"88","author":"McCusker","year":"2003","journal-title":"Gynecol Oncol"},{"issue":"6","key":"10.1053\/j.sult.2026.06.014_bib5","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1097\/AOG.0b013e318173570b","article-title":"Incidence, mortality, and prognostic factors of small cell carcinoma of the cervix","volume":"111","author":"Chen","year":"2008","journal-title":"Obstet Gynecol"},{"issue":"1","key":"10.1053\/j.sult.2026.06.014_bib6","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.ygyno.2011.04.011","article-title":"Neuroendocrine tumors of the gynecologic tract: A Society of Gynecologic Oncology (SGO) clinical document","volume":"122","author":"Gardner","year":"2011","journal-title":"Gynecol Oncol"},{"issue":"4","key":"10.1053\/j.sult.2026.06.014_bib7","article-title":"Neuroendocrine tumors of the gynecological tract: A narrative literature review","volume":"51","author":"\u010celebi\u0107","year":"2025","journal-title":"Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol"},{"issue":"1","key":"10.1053\/j.sult.2026.06.014_bib8","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s12022-022-09708-2","article-title":"Overview of the 2022 WHO Classification of Neuroendocrine Neoplasms","volume":"33","author":"Rindi","year":"2022","journal-title":"Endocr Pathol"},{"issue":"17","key":"10.1053\/j.sult.2026.06.014_bib9","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2321898121","article-title":"Integrated mutational landscape analysis of poorly differentiated high-grade neuroendocrine carcinoma of the uterine cervix","volume":"121","author":"Bellone","year":"2024","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"10.1053\/j.sult.2026.06.014_bib10","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.ygyno.2016.11.020","article-title":"A new marker, insulinoma-associated protein 1 (INSM1), for high-grade neuroendocrine carcinoma of the uterine cervix: Analysis of 37 cases","volume":"144","author":"Kuji","year":"2017","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1053\/j.sult.2026.06.014_bib11","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.ygyno.2017.12.001","article-title":"A systematic review and meta-analysis on the attribution of human papillomavirus (HPV) in neuroendocrine cancers of the cervix","volume":"148","author":"Castle","year":"2018","journal-title":"Gynecol Oncol"},{"issue":"4","key":"10.1053\/j.sult.2026.06.014_bib12","article-title":"Neuroendocrine cervical cancer: Have we made any steps forward in its management?","volume":"51","author":"Mandic","year":"2025","journal-title":"Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol"},{"issue":"1","key":"10.1053\/j.sult.2026.06.014_bib13","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/00000478-199101000-00003","article-title":"Small-cell neuroendocrine carcinoma of the cervix: A human papillomavirus type 18-associated cancer","volume":"15","author":"Stoler","year":"1991","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.sult.2026.06.014_bib14","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.pvr.2018.03.005","article-title":"Contribution of human papillomavirus in neuroendocrine tumors from a series of 10,575 invasive cervical cancer cases","volume":"5","author":"Alejo","year":"2018","journal-title":"Papillomavirus Res"},{"issue":"9","key":"10.1053\/j.sult.2026.06.014_bib15","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1136\/ijgc-2020-001649","article-title":"Evaluation of PARP and PDL-1 as potential therapeutic targets for women with high-grade neuroendocrine carcinomas of the cervix","volume":"30","author":"Carroll","year":"2020","journal-title":"Int J Gynecol Cancer J Int Gynecol Cancer Soc"},{"issue":"7","key":"10.1053\/j.sult.2026.06.014_bib16","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.3390\/cancers14071835","article-title":"Neuroendocrine neoplasms of the gynecologic tract","volume":"14","author":"Virarkar","year":"2022","journal-title":"Cancers"},{"issue":"1","key":"10.1053\/j.sult.2026.06.014_bib17","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/ijgo.12749","article-title":"Revised FIGO staging for carcinoma of the cervix uteri","volume":"145","author":"Bhatla","year":"2019","journal-title":"Int J Gynecol Obstet"},{"issue":"6","key":"10.1053\/j.sult.2026.06.014_bib18","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1148\/rg.2020200013","article-title":"2018 FIGO staging classification for cervical cancer: Added benefits of imaging","volume":"40","author":"Salib","year":"2020","journal-title":"RadioGraphics"},{"issue":"7","key":"10.1053\/j.sult.2026.06.014_bib19","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1586\/14737140.2015.1047767","article-title":"Challenges in the diagnosis and management of cervical neuroendocrine carcinoma","volume":"15","author":"Burzawa","year":"2015","journal-title":"Expert Rev Anticancer Ther"},{"issue":"3","key":"10.1053\/j.sult.2026.06.014_bib20","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.ygyno.2013.02.025","article-title":"Diagnosis, clinicopathologic features, treatment, and prognosis of small cell carcinoma of the uterine cervix; Kansai Clinical Oncology Group\/Intergroup study in Japan","volume":"129","author":"Kuji","year":"2013","journal-title":"Gynecol Oncol"},{"issue":"5","key":"10.1053\/j.sult.2026.06.014_bib21","doi-asserted-by":"crossref","first-page":"633","DOI":"10.2214\/AJR.23.29003","article-title":"Staging of cervical cancer: A practical approach using MRI and FDG PET","volume":"221","author":"Lakhman","year":"2023","journal-title":"AJR Am J Roentgenol"},{"issue":"11","key":"10.1053\/j.sult.2026.06.014_bib22","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1136\/ijgc-2023-004907","article-title":"PET\/CT scan improves detection of metastatic disease compared with CT scan alone in women with high-grade neuroendocrine cervical cancer: A NeCTuR study","volume":"33","author":"Frumovitz","year":"2023","journal-title":"Int J Gynecol Cancer"},{"issue":"15","key":"10.1053\/j.sult.2026.06.014_bib23","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.70066","article-title":"Causes of death analysis and the prognostic model construction in neuroendocrine carcinoma of the cervix: A SEER-based study","volume":"13","author":"Yu","year":"2024","journal-title":"Cancer Med"},{"issue":"6","key":"10.1053\/j.sult.2026.06.014_bib24","doi-asserted-by":"crossref","DOI":"10.1111\/jne.13394","article-title":"Small-cell neuroendocrine carcinoma of the female genital tract: A comprehensive overview","volume":"36","author":"Saraei","year":"2024","journal-title":"J Neuroendocrinol"},{"issue":"18","key":"10.1053\/j.sult.2026.06.014_bib25","doi-asserted-by":"crossref","first-page":"3495","DOI":"10.1200\/JCO.2003.01.501","article-title":"Small-cell carcinoma of the cervix: Fourteen years of experience at a single institution using a combined-modality regimen of involved-field irradiation and platinum-based combination chemotherapy","volume":"21","author":"Hoskins","year":"2003","journal-title":"J Clin Oncol J Am Soc Clin Oncol"},{"key":"10.1053\/j.sult.2026.06.014_bib26","article-title":"Clinical outcomes of neuroendocrine carcinoma of the cervix: Retrospective review from a large academic cancer centre","volume":"61","author":"Fernandes","year":"2025","journal-title":"Gynecol Oncol Rep"},{"issue":"3","key":"10.1053\/j.sult.2026.06.014_bib27","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1002\/ijgo.15771","article-title":"Clinicopathologic characteristics and prognostic factors of patients with surgically treated high-grade neuroendocrine carcinoma of the cervix: A multicenter retrospective study","volume":"167","author":"Lyu","year":"2024","journal-title":"Int J Gynaecol Obstet Organ Int Fed Gynaecol Obstet"},{"issue":"3","key":"10.1053\/j.sult.2026.06.014_bib28","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.ygyno.2017.09.022","article-title":"Cycles of cisplatin and etoposide affect treatment outcomes in patients with FIGO stage I-II small cell neuroendocrine carcinoma of the cervix","volume":"147","author":"Pei","year":"2017","journal-title":"Gynecol Oncol"},{"key":"10.1053\/j.sult.2026.06.014_bib29","article-title":"Prognostic value of apparent diffusion coefficient in neuroendocrine carcinomas of the uterine cervix","volume":"11","author":"Chen","year":"2023","journal-title":"PeerJ"},{"issue":"4","key":"10.1053\/j.sult.2026.06.014_bib30","doi-asserted-by":"crossref","DOI":"10.3802\/jgo.2023.34.e50","article-title":"RB1 alteration and poor prognosis in women with high-grade neuroendocrine carcinoma of the uterine cervix: A NeCTuR study","volume":"34","author":"Flores Legarreta","year":"2023","journal-title":"J Gynecol Oncol"},{"issue":"11","key":"10.1053\/j.sult.2026.06.014_bib31","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.3390\/cancers16111983","article-title":"Systematic review\u2014Role of MRI in cervical cancer staging","volume":"16","author":"Chen","year":"2024","journal-title":"Cancers"},{"issue":"3","key":"10.1053\/j.sult.2026.06.014_bib32","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1148\/radiol.12120315","article-title":"The added role of MR imaging in treatment stratification of patients with gynecologic malignancies: What the radiologist needs to know","volume":"266","author":"Sala","year":"2013","journal-title":"Radiology"},{"key":"10.1053\/j.sult.2026.06.014_bib33","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.mri.2024.07.010","article-title":"Dynamic contrast-enhanced and diffusion-weighted MRI of cervical carcinoma: Correlations with Ki-67 proliferation status","volume":"112","author":"Lai","year":"2024","journal-title":"Magn Reson Imag"},{"issue":"12","key":"10.1053\/j.sult.2026.06.014_bib34","doi-asserted-by":"crossref","first-page":"4293","DOI":"10.1007\/s00330-016-4327-1","article-title":"MR imaging features and staging of neuroendocrine carcinomas of the uterine cervix with pathological correlations","volume":"26","author":"Duan","year":"2016","journal-title":"Eur Radiol"},{"issue":"40","key":"10.1053\/j.sult.2026.06.014_bib35","doi-asserted-by":"crossref","first-page":"3675","DOI":"10.18632\/oncotarget.27613","article-title":"Neuroendocrine carcinoma of uterine cervix findings shown by MRI for staging and survival analysis \u2013 Japan multicenter study","volume":"11","author":"Kitajima","year":"2020","journal-title":"Oncotarget"},{"issue":"10","key":"10.1053\/j.sult.2026.06.014_bib36","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.crad.2019.07.003","article-title":"Assessment of parametrial invasion of cervical carcinoma, the role of T2-weighted MRI and diffusion weighted imaging with or without fusion","volume":"74","author":"Mongula","year":"2019","journal-title":"Clin Radiol"},{"issue":"6","key":"10.1053\/j.sult.2026.06.014_bib37","first-page":"1539","article-title":"MR imaging of cervical carcinoma: A practical staging approach","volume":"20","author":"Nicolet","year":"2000","journal-title":"Radiogr Rev Publ Radiol Soc N Am Inc"},{"issue":"12","key":"10.1053\/j.sult.2026.06.014_bib38","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.6004\/jnccn.2023.0062","article-title":"NCCN Guidelines\u00ae Insights: Cervical Cancer, Version 1.2024","volume":"21","author":"Abu-Rustum","year":"2023","journal-title":"J Natl Compr Cancer Netw JNCCN"},{"key":"10.1053\/j.sult.2026.06.014_bib39","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1012491","article-title":"Survival effect of pre-RT PET-CT on cervical cancer: Image-guided intensity-modulated radiation therapy era","volume":"13","author":"Su","year":"2023","journal-title":"Front Oncol"},{"issue":"6","key":"10.1053\/j.sult.2026.06.014_bib40","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1111\/j.1349-7006.2010.01532.x","article-title":"Diagnostic performance of computer tomography, magnetic resonance imaging, and positron emission tomography or positron emission tomography\/computer tomography for detection of metastatic lymph nodes in patients with cervical cancer: Meta-analysis","volume":"101","author":"Choi","year":"2010","journal-title":"Cancer Sci"},{"issue":"8","key":"10.1053\/j.sult.2026.06.014_bib41","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1097\/IGC.0000000000000519","article-title":"Complementary prognostic value of pelvic magnetic resonance imaging and whole-body fluorodeoxyglucose positron emission tomography\/ computed tomography in the pretreatment assessment of patients with cervical cancer","volume":"25","author":"Sala","year":"2015","journal-title":"Int J Gynecol Cancer"},{"issue":"6","key":"10.1053\/j.sult.2026.06.014_bib42","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1053\/j.semnuclmed.2021.06.006","article-title":"PET\/CT variants and pitfalls in gynecological cancers","volume":"51","author":"Dejanovic","year":"2021","journal-title":"Semin Nucl Med"},{"issue":"11","key":"10.1053\/j.sult.2026.06.014_bib43","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1097\/RLU.0000000000006103","article-title":"18 F-FAPI-04 PET\/CT in the evaluation of patients with cervical cancers: Head-to-head comparison with 18 F-FDG PET\/CT","volume":"50","author":"Wei","year":"2025","journal-title":"Clin Nucl Med"},{"key":"10.1053\/j.sult.2026.06.014_bib44","unstructured":"Diagnostic role of Gallium-68 DOTATOC and Gallium-68 DOTATATE PET in patients with neuroendocrine tumors: A meta-analysis - Jigang Yang, Ying Kan, Benjamin H Ge, Leilei Yuan, Chunlin Li, Wenrui Zhao, 2014. Accessed January 13, 2026."},{"issue":"6","key":"10.1053\/j.sult.2026.06.014_bib45","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1136\/ijgc-2019-000504","article-title":"Updates and management algorithm for neuroendocrine tumors of the uterine cervix","volume":"29","author":"Salvo","year":"2019","journal-title":"Int J Gynecol Cancer"},{"issue":"15_suppl","key":"10.1053\/j.sult.2026.06.014_bib46","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2018.36.15_suppl.5534","article-title":"Dose dense neoadjuvant chemotherapy (NACT) with carboplatin-paclitaxel in locally advanced cervical cancer","volume":"36","author":"Lorusso","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.sult.2026.06.014_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2025.112566","article-title":"Timing of MRI for early treatment response prediction of chemoradiotherapy in uterine cervical cancer","volume":"195","author":"Fridsten","year":"2026","journal-title":"Eur J Radiol"},{"issue":"8","key":"10.1053\/j.sult.2026.06.014_bib48","doi-asserted-by":"crossref","DOI":"10.1530\/ERC-22-0206","article-title":"Expert consensus practice recommendations of the North American Neuroendocrine Tumor Society for the management of high grade gastroenteropancreatic and gynecologic neuroendocrine neoplasms","volume":"30","author":"Eads","year":"2023","journal-title":"Endocr Relat Cancer"},{"issue":"1","key":"10.1053\/j.sult.2026.06.014_bib49","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ygyno.2016.10.040","article-title":"Combination therapy with topotecan, paclitaxel, and bevacizumab improves progression-free survival in recurrent small cell neuroendocrine carcinoma of the cervix","volume":"144","author":"Frumovitz","year":"2017","journal-title":"Gynecol Oncol"},{"issue":"19","key":"10.1053\/j.sult.2026.06.014_bib50","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1001\/jama.298.19.2289","article-title":"Association of posttherapy positron emission tomography with tumor response and survival in cervical carcinoma","volume":"298","author":"Schwarz","year":"2007","journal-title":"JAMA"},{"key":"10.1053\/j.sult.2026.06.014_bib51","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s40644-025-00843-7","article-title":"Head-to-head comparison of 18F-FDG and 68Ga-FAPI PET\/CT in common gynecological malignancies","volume":"25","author":"Li","year":"2025","journal-title":"Cancer Imag"},{"issue":"6","key":"10.1053\/j.sult.2026.06.014_bib52","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1053\/j.semnuclmed.2019.06.008","article-title":"A role of PET agents beyond FDG in gynecology","volume":"49","author":"Ponisio","year":"2019","journal-title":"Semin Nucl Med"},{"key":"10.1053\/j.sult.2026.06.014_bib53","doi-asserted-by":"crossref","first-page":"iv72","DOI":"10.1093\/annonc\/mdx220","article-title":"Cervical cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"28","author":"Marth","year":"2017","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1053\/j.sult.2026.06.014_bib54","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1006\/gyno.2000.6118","article-title":"Multimodality therapy in early-stage neuroendocrine carcinoma of the uterine cervix","volume":"81","author":"Boruta","year":"2001","journal-title":"Gynecol Oncol"},{"issue":"4","key":"10.1053\/j.sult.2026.06.014_bib55","doi-asserted-by":"crossref","first-page":"347.e1","DOI":"10.1016\/j.ajog.2010.04.019","article-title":"Small cell carcinoma of the cervix: Treatment and survival outcomes of 188 patients","volume":"203","author":"Cohen","year":"2010","journal-title":"Am J Obstet Gynecol"},{"key":"10.1053\/j.sult.2026.06.014_bib56","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ygyno.2025.11.015","article-title":"Surgery versus definitive radiotherapy in the management of stage I-II small cell neuroendocrine carcinoma of the cervix: A systematic review and meta-analysis","volume":"204","author":"Fan","year":"2025","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1053\/j.sult.2026.06.014_bib57","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.ygyno.2016.09.011","article-title":"Patterns of recurrence and survival in neuroendocrine cervical cancer","volume":"143","author":"Stecklein","year":"2016","journal-title":"Gynecol Oncol"},{"issue":"1","key":"10.1053\/j.sult.2026.06.014_bib58","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.ygyno.2017.10.027","article-title":"Prognostic factors and optimal therapy for stages I-II neuroendocrine carcinomas of the uterine cervix: A multi-center retrospective study","volume":"148","author":"Ishikawa","year":"2018","journal-title":"Gynecol Oncol"},{"issue":"3","key":"10.1053\/j.sult.2026.06.014_bib59","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.ygyno.2008.11.010","article-title":"Small cell neuroendocrine carcinoma of the cervix: Analysis of outcome, recurrence pattern and the impact of platinum-based combination chemotherapy","volume":"112","author":"Zivanovic","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1053\/j.sult.2026.06.014_bib60","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1652092","article-title":"Prognostic value of inflammatory markers and different treatment regimens in neuroendocrine cervical carcinoma: A retrospective study","volume":"16","author":"Kuang","year":"2025","journal-title":"Front Pharmacol"},{"issue":"2","key":"10.1053\/j.sult.2026.06.014_bib61","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1093\/annonc\/mdm465","article-title":"Prognostic factors in FIGO stage IB-IIA small cell neuroendocrine carcinoma of the uterine cervix treated surgically: Results of a multi-center retrospective Korean study","volume":"19","author":"Lee","year":"2008","journal-title":"Ann Oncol J Eur Soc Med Oncol"},{"issue":"2","key":"10.1053\/j.sult.2026.06.014_bib62","doi-asserted-by":"crossref","DOI":"10.1177\/00368504211009336","article-title":"The role of radiotherapy in neuroendocrine cervical cancer: SEER-based study","volume":"104","author":"Dong","year":"2021","journal-title":"Sci Prog"},{"key":"10.1053\/j.sult.2026.06.014_bib63","first-page":"9","article-title":"Radiotherapy can improve overall survival in patients with lymph-node positive, high-grade neuroendocrine cervical cancer: Construction of two prognostic nomograms to predict treatment outcome","volume":"14","author":"Zhang","year":"2024","journal-title":"Front Oncol"},{"key":"10.1053\/j.sult.2026.06.014_bib64","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.gore.2016.10.002","article-title":"Fertility sparing management of large cell neuroendocrine tumour of cervix: A case report & review of literature","volume":"18","author":"Rajkumar","year":"2016","journal-title":"Gynecol Oncol Rep"},{"issue":"1","key":"10.1053\/j.sult.2026.06.014_bib65","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s12905-017-0404-0","article-title":"Case report: Term birth after fertility-sparing treatments for stage IB1 small cell neuroendocrine carcinoma of the cervix","volume":"17","author":"Wu","year":"2017","journal-title":"BMC Women\u2019s Health"},{"issue":"1","key":"10.1053\/j.sult.2026.06.014_bib66","doi-asserted-by":"crossref","first-page":"64","DOI":"10.6004\/jnccn.2019.0001","article-title":"Cervical Cancer, Version 3.2019, NCCN Clinical Practice Guidelines in Oncology","volume":"17","author":"Koh","year":"2019","journal-title":"J Natl Compr Cancer Netw JNCCN"},{"issue":"10","key":"10.1053\/j.sult.2026.06.014_bib67","first-page":"1484","article-title":"Primary treatment and prognostic factors of small cell neuroendocrine carcinoma of the uterine cervix: A Taiwanese Gynecologic Oncology Group study","volume":"48","author":"Wang","year":"2012","journal-title":"Eur J Cancer Oxf Engl 1990"},{"key":"10.1053\/j.sult.2026.06.014_bib68","doi-asserted-by":"crossref","first-page":"S85","DOI":"10.1016\/j.ijrobp.2018.06.226","article-title":"Small cell carcinoma of the cervix: Definitive chemoradiation for locally advanced disease","volume":"102","author":"Bajaj","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6","key":"10.1053\/j.sult.2026.06.014_bib69","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.brachy.2016.08.007","article-title":"Brachytherapy should not be omitted when treating locally advanced neuroendocrine cervical cancer with definitive chemoradiation therapy","volume":"15","author":"Robin","year":"2016","journal-title":"Brachytherapy"},{"issue":"14","key":"10.1053\/j.sult.2026.06.014_bib70","doi-asserted-by":"crossref","first-page":"4743","DOI":"10.1002\/cam4.4034","article-title":"PD-L1, PARP1, and MMRs as potential therapeutic biomarkers for neuroendocrine cervical cancer","volume":"10","author":"Ji","year":"2021","journal-title":"Cancer Med."},{"issue":"1","key":"10.1053\/j.sult.2026.06.014_bib71","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s40661-017-0038-9","article-title":"Metastatic small cell neuroendocrine carcinoma of the cervix treated with the PD-1 inhibitor, nivolumab: A case report","volume":"4","author":"Paraghamian","year":"2017","journal-title":"Gynecol Oncol Res Pract"},{"issue":"6","key":"10.1053\/j.sult.2026.06.014_bib72","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1634\/theoncologist.2016-0517","volume":"22","author":"Sharabi","year":"2017","journal-title":"Oncologist"},{"key":"10.1053\/j.sult.2026.06.014_bib73","article-title":"Ipilimumab and nivolumab for recurrent neuroendocrine cervical carcinoma","volume":"42","author":"Towner","year":"2022","journal-title":"Gynecol Oncol Rep"},{"issue":"14","key":"10.1053\/j.sult.2026.06.014_bib74","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1056\/NEJMoa2404873","article-title":"Durvalumab after chemoradiotherapy in limited-stage small-cell lung cancer","volume":"391","author":"Cheng","year":"2024","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1053\/j.sult.2026.06.014_bib75","doi-asserted-by":"crossref","first-page":"4741","DOI":"10.21873\/anticanres.14475","article-title":"Adoptive immune-cell therapy for the treatment of neuroendocrine carcinoma of the uterine cervix","volume":"40","author":"Goto","year":"2020","journal-title":"Anticancer Res"}],"container-title":["Seminars in Ultrasound, CT and MRI"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088721712600034X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088721712600034X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T16:30:16Z","timestamp":1789749016000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S088721712600034X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":75,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S088721712600034X"],"URL":"https:\/\/doi.org\/10.1053\/j.sult.2026.06.014","relation":{},"ISSN":["0887-2171"],"issn-type":[{"value":"0887-2171","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuroendocrine Carcinoma of Cervix: Comprehensive Review of Epidemiology, Pathology, and Advanced Imaging Modalities","name":"articletitle","label":"Article Title"},{"value":"Seminars in Ultrasound, CT and MRI","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.sult.2026.06.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}